Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|October 14, 2025
Dabogratinib (TYRA-300), an FGFR3 isoform-selective inhibitor: preclinical and initial clinical evidence of anti-tumor activityJacqueline H Starrett, Eric L Allen, Melissa Neal, et al.
Plos One|January 20, 2017
Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery DiseaseAna María Pello Lázaro, Carmen Cristóbal, Juan Antonio Franco-Peláez, et al.
Cancers|March 6, 2021
Mapping of Genomic Vulnerabilities in the Post-Translational Ubiquitination, SUMOylation and Neddylation Machinery in Breast CancerJesús Fuentes-Antrás, Ana Lucía Alcaraz-Sanabria, Esther Cabañas Morafraile, et al.
Cancers|August 27, 2021
Genomic Mapping of Splicing-Related Genes Identify Amplifications in <i>LSM1</i>, <i>CLNS1A,</i> and <i>ILF2</i> in Luminal Breast CancerMaría Del Mar Noblejas-López, Igor López-Cade, Jesús Fuentes-Antrás, et al.
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
International Journal of Cancer|December 3, 2020
A snapshot of COVID-19 infection in patients with solid tumorsJesús Fuentes-Antrás, Aránzazu Manzano, Gloria Marquina, et al.
Nature Communications|June 11, 2026
Oligoclonal expansion of atypical Vδ2<sup>-</sup> γδ T cells in Good's SyndromeEsther Bandala-Sanchez, Laura Scolamiero, Josh Chatelier, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
International Journal of Molecular Sciences|July 29, 2023
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase InhibitorsJesús Fuentes-Antrás, Ana Martínez-Rodríguez, Kissy Guevara-Hoyer, et al.
Pageof 5